C19orf67
UPF0575 protein C19orf67
Also known as: CS067_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NJJ6
- Gene
- C19orf67
- Ensembl
- ENSG00000188032
- Chromosome
- 19
- Canonical length
- 358 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
Predicted to act upstream of or within in utero embryonic development. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
358 residues, UniProt reviewed canonical sequence.
>A6NJJ6|C19orf67
1 MATEQWFEGS LPLDPGETPP PDALEPGTPP CGDPSRSTPP GRPGNPSEPD PEDAEGRLAE
61 ARASTSSPKP LVPRPGPAPP RLSLDTLFSP ITQQLRYLLK KADDFQSYLL YSRDQVQKEQ
121 LAKAMPTFLQ MCEPYFLYLE AAARSIPPIY GPLQELVRKG LLEISQQLTL RLEQLVLMYA
181 SFGFVDLEEM NPLSISCFFC GRFSISLSHE VSIFRYCAPT AYTASRFPRY LYKKMRWHLE
241 ATPEAPGRGQ DSLVDYYFLC YRDTWEDTGQ SPANSCPQIQ KLWSIGRWVP LGPAEDDLYS
301 WILCPQPLGD YQQLLTIGFE EPTPTLATDL LVQILTGQAG QARPPSAAGP AGWAAQGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C19orf67 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 6.4 nTPM
Expression across tissuesHPA
Tissue
- testis: 6.4 nTPM
- stomach: 0.2 nTPM
- cervix: 0.1 nTPM
- colon: 0.1 nTPM
- fallopian tube: 0.1 nTPM
- kidney: 0.1 nTPM
Single-cell type
- late primary spermatocytes: 9.6 nCPM
- late spermatids: 9.3 nCPM
- early spermatids: 8 nCPM
- oocytes: 4.6 nCPM
- respiratory ciliated cells: 0.3 nCPM
- renal collecting duct intercalated cells: 0.2 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 1 nTPM
- cerebral cortex: 0.8 nTPM
- midbrain: 0.8 nTPM
- spinal cord: 0.8 nTPM
- thalamus: 0.8 nTPM
- white matter: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.75
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Protein domainsUniProt · Pfam · InterPro
- Protein of unknown function DUF3314
- Protein of unknown function (DUF3314)
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C19orf67 as an antibody target. Whether an autoantibody or antibody against C19orf67 could matter depends on whether native C19orf67 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C19orf67 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C19orf67 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...